Medical Treatment & Prevention

Description

No matching items found.

People

  

  

  

1 of 8

  

  

  

• ALUCK THIPAYARAT
• BOONSERM KAEWKAMNERDPONG
• CHANYAPORN BSTIELER
• DUANGHATHAI WIWATRATANA
• DUJDUAN WARAHO

Publications

  

  

  

14 of 17

  

  

  

• ● Repurposing phone booths into COVID-19 sampling stations: medical operator experiences; Martin Schoch and Sunaree Lawanywatna; 2024; Journal article review
• ● Selection of the membrane for centrifugal ultrafiltration and protein profile analysis of human primary keratinocyte secretome ; Natthakit Bunkam and Kwanchnok Viravaidya-Pasuwat ; 2024; Conference proceedings article
• ● Shared neural network interactions underlying visual cognition, attentional reorientation, and executive function across developmental stages; C. Kitkana , C. Pamarapa , W. Lert-itthiporn , et al.; 2024; Poster
• ● Sitting Posture Detection and Classification Using Machine Learning Algorithms on RapidMiner; Sri-ngernyuang, C., Prakrankiat Youngkong, et al.; 2025; Journal article
• ● Suppression of the inflammatory response by oxyresveratrol from the root bark of Artocarpus lakoocha Roxb against ultraviolet B-induced keratinocytes mediated by regulating p38 MAPK and AP-1; Kittiya Malaniyoma, Piyanee Ratanachamnongb, Poommaree Namchaiwc, et al.; 2024; Journal article

Projects

  

  

  

1 of 3

  

  

  

• ● Characterizing tissue biomechanical properties for development of artificial tissue; TEERANOOT CHANTHASOPEEPHAN - Department of Mechanical Engineering
• ● Cosmeceutical mask sheet for skin care whitening and antiaging agent using innovative cellulose acetate electrospun fibers doped with a natural oxyresveratal ; NAKORN NIAMNONT - Department of Chemistry
• ● Development of a phototriggerable liposomal delivery system for emblica fruit extract for the treatment of psoriasis; KWANCHANOK PASUWAT - Department of Chemical Engineering
• ● Development of nanobodies specific to the CHRD domain of proprotein convertase subtilisin/kexin type 9 (PCSK9) as biologics for treatment of high blood LDL-cholesterol level; DUJDUAN WARAHO - Faculty of Engineering
• ● Development of nanobody specific to receptor binding domain of SARS-CoV-2 for applying as antibody drug for COVID-19 treatment; DUJDUAN WARAHO - Faculty of Engineering